While details on the new Ninja are unknown, Moto Blast thinks it would be called the Kawasaki Ninja 250 SL. It will feature a single-cylinder engine.

SL-401 is biologic conjugate that targets the interleukin-3 (IL-3) receptor. For more information call (212) 831-1111 or visit www.stemline.com.

Stemline Therapeutics' Lead Clinical Candidate, SL-401, Induces Another Complete Response in a Patient with a Drug-Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm NEW YORK, Jan. 7, 2013 ...

Leukemia - A novel agent SL-401 induces anti-myeloma activity by targeting plasmacytoid dendritic cells, osteoclastogenesis and cancer stem-like cells. Skip to main content.

* Stemline Therapeutics presents SL-401 updated stage 1 and 2 data from ongoing pivotal trial in BPDCN and safety experience across multiple indications, today at EHA Sign up here. * Stage 3 is ...